{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T02:49:47Z","timestamp":1783997387297,"version":"3.55.0"},"reference-count":52,"publisher":"Impact Journals, LLC","issue":"55","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,11,7]]},"DOI":"10.18632\/oncotarget.21885","type":"journal-article","created":{"date-parts":[[2017,10,19]],"date-time":"2017-10-19T05:36:16Z","timestamp":1508391376000},"page":"94711-94725","source":"Crossref","is-referenced-by-count":13,"title":["Bioenergetics of acquired cisplatin resistant H1299 non-small cell lung cancer and P31 mesothelioma cells"],"prefix":"10.18632","volume":"8","author":[{"given":"Fintan","family":"Geoghegan","sequence":"first","affiliation":[{"name":"School of Biochemistry and Immunology, Trinity Biomedical Science Institute (TBSI), Trinity College Dublin, Dublin 2, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Buckland","sequence":"additional","affiliation":[{"name":"Dept of Medical Biosciences, Clinical Chemistry, Ume\u00e5 University, Ume\u00e5, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric T.","family":"Rogers","sequence":"additional","affiliation":[{"name":"School of Biochemistry and Immunology, Trinity Biomedical Science Institute (TBSI), Trinity College Dublin, Dublin 2, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karima","family":"Khalifa","sequence":"additional","affiliation":[{"name":"School of Biochemistry and Immunology, Trinity Biomedical Science Institute (TBSI), Trinity College Dublin, Dublin 2, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma B.","family":"O\u2019Connor","sequence":"additional","affiliation":[{"name":"School of Biochemistry and Immunology, Trinity Biomedical Science Institute (TBSI), Trinity College Dublin, Dublin 2, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary F.","family":"Rooney","sequence":"additional","affiliation":[{"name":"School of Biochemistry and Immunology, Trinity Biomedical Science Institute (TBSI), Trinity College Dublin, Dublin 2, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parviz","family":"Behnam-Motlagh","sequence":"additional","affiliation":[{"name":"Dept of Medical Biosciences, Clinical Chemistry, Ume\u00e5 University, Ume\u00e5, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torbj\u00f6rn K.","family":"Nilsson","sequence":"additional","affiliation":[{"name":"Dept of Medical Biosciences, Clinical Chemistry, Ume\u00e5 University, Ume\u00e5, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjell","family":"Grankvist","sequence":"additional","affiliation":[{"name":"Dept of Medical Biosciences, Clinical Chemistry, Ume\u00e5 University, Ume\u00e5, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard K.","family":"Porter","sequence":"additional","affiliation":[{"name":"School of Biochemistry and Immunology, Trinity Biomedical Science Institute (TBSI), Trinity College Dublin, Dublin 2, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,10,16]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Weinberg","year":"2011","journal-title":"Cell"},{"key":"2","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1074\/jbc.M109.077271","article-title":"Exogenous NAD blocks cardiac hypertrophic response via activation of the SIRT3-LKB1-AMP-activated kinase pathway","volume":"285","author":"Gupta","year":"2010","journal-title":"J Biol Chem"},{"key":"3","doi-asserted-by":"publisher","first-page":"15983","DOI":"10.1073\/pnas.252625599","article-title":"AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation","volume":"99","author":"Shulman","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1152\/japplphysiol.00900.2007","article-title":"AMP-activated protein kinase phosphorylates transcription factors of the CREB family","volume":"104","author":"Winder","year":"2008","journal-title":"J Appl Physiol"},{"key":"5","doi-asserted-by":"publisher","first-page":"3884","DOI":"10.1093\/nar\/gkt1356","article-title":"A novel intermediate in transcription initiation by human mitochondrial RNA polymerase","volume":"42","author":"Temiakov","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"6","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1038\/ncomms4077","article-title":"Distinct structural features of TFAM drive mitochondrial DNA packaging versus transcriptional activation","volume":"5","author":"Chan","year":"2014","journal-title":"Nat Commun"},{"key":"7","doi-asserted-by":"publisher","first-page":"7265","DOI":"10.1038\/sj.onc.1206933","article-title":"Cisplatin: mode of cytotoxic action and molecular basis of resistance","volume":"22","author":"Siddik","year":"2003","journal-title":"Oncogene"},{"key":"8","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.3390\/toxins2102467","article-title":"Verotoxin-1 treatment or manipulation of its receptor globotriaosylceramide (gb3) for reversal of multidrug resistance to cancer chemotherapy","volume":"2","author":"Johansson","year":"2010","journal-title":"Toxins (Basel)"},{"key":"9","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3727\/096504005776568273","article-title":"Adenylate cyclase toxin from Bordetella pertussis enhances cisplatin-induced apoptosis to lung cancer cells","volume":"15","author":"Behnam-Motlagh","year":"2006","journal-title":"Oncol Res"},{"key":"10","first-page":"949","article-title":"Preferential binding of cisplatin to mitochondrial DNA and suppression of ATP generation in human malignant melanoma cells","volume":"20","author":"Nakashima","year":"1990","journal-title":"Biochem Int"},{"key":"11","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/0165-7992(95)90039-X","article-title":"Preferential binding of cisplatin to mitochondrial DNA of Chinese hamster ovary cells","volume":"346","author":"Poirier","year":"1995","journal-title":"Mutat Res"},{"key":"12","doi-asserted-by":"publisher","first-page":"C1466","DOI":"10.1152\/ajpcell.00265.2005","article-title":"Mitochondrial density determines the cellular sensitivity to cisplatin-induced cell death","volume":"289","author":"Inoue","year":"2005","journal-title":"Am J Physiol Cell Physiol"},{"key":"13","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/path.1706","article-title":"Molecular mechanisms of drug resistance","volume":"205","author":"Johnston","year":"2005","journal-title":"J Pathol"},{"key":"14","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1158\/1541-7786.MCR-07-2130","article-title":"SIRT1 contributes in part to cisplatin resistance in cancer cells by altering mitochondrial metabolism","volume":"6","author":"Gottesman","year":"2008","journal-title":"Mol Cancer Res"},{"key":"15","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/sj.bjc.6605467","article-title":"Cisplatin-induced expression of Gb3 enables verotoxin-1 treatment of cisplatin resistance in malignant pleural mesothelioma cells","volume":"102","author":"Behnam-Motlagh","year":"2010","journal-title":"Br J Cancer"},{"key":"16","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.canlet.2016.01.009","article-title":"Overcoming cisplatin resistance of ovarian cancer cells by targeting HIF-1-regulated cancer metabolism","volume":"373","author":"Fan","year":"2016","journal-title":"Cancer Lett"},{"key":"17","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1177\/1535370213493069","article-title":"Oxidative stress response elicited by mitochondrial dysfunction: implication in the pathophysiology of aging","volume":"238","author":"Wei","year":"2013","journal-title":"Exp Biol Med (Maywood)"},{"key":"18","doi-asserted-by":"publisher","first-page":"C125","DOI":"10.1152\/ajpcell.00247.2006","article-title":"Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells","volume":"292","author":"Ferrick","year":"2007","journal-title":"Am J Physiol Cell Physiol"},{"key":"19","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for cancer therapy","volume":"3","author":"Semenza","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"20","doi-asserted-by":"publisher","first-page":"1250256","DOI":"10.1126\/science.1250256","article-title":"Cell biology. Metabolic control of cell death","volume":"345","author":"Kroemer","year":"2014","journal-title":"Science"},{"key":"21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/ajco.12419","article-title":"Synergistic antitumor activity of pro-apoptotic agent PAC-1 with cisplatinum by the activation of CASP3 in pulmonary adenocarcinoma cell line H1299","volume":"12","author":"Jin","year":"2016","journal-title":"Asia Pac J Clin Oncol"},{"key":"22","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1159\/000149782","article-title":"Acquisition of cisplatin-resistance in malignant mesothelioma cells abrogates Na+,K+,2Cl(-)-cotransport activity and cisplatin-induced early membrane blebbing","volume":"22","author":"Grankvist","year":"2008","journal-title":"Cell Physiol Biochem"},{"key":"23","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.yexcr.2015.05.012","article-title":"Targeting glucosylceramide synthase induction of cell surface globotriaosylceramide (Gb3) in acquired cisplatin-resistance of lung cancer and malignant pleural mesothelioma cells","volume":"336","author":"Behnam-Motlagh","year":"2015","journal-title":"Exp Cell Res"},{"key":"24","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1038\/bjc.2014.165","article-title":"Wild-type and mutant p53 differentially regulate NADPH oxidase 4 in TGF-beta-mediated migration of human lung and breast epithelial cells","volume":"110","author":"Leto","year":"2014","journal-title":"Br J Cancer"},{"key":"25","doi-asserted-by":"publisher","first-page":"74132","DOI":"10.18632\/oncotarget.12356","article-title":"Mitochondrial dysfunction enhances cisplatin resistance in human gastric cancer cells via the ROS-activated GCN2-eIF2alpha-ATF4-xCT pathway","volume":"7","author":"Lee","year":"2016","journal-title":"Oncotarget"},{"key":"26","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nrc706","article-title":"Multidrug resistance in cancer: role of ATP-dependent transporters","volume":"2","author":"Bates","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"27","doi-asserted-by":"publisher","first-page":"4018","DOI":"10.1158\/0008-5472.CAN-07-6334","article-title":"Is tumor growth sustained by rare cancer stem cells or dominant clones?","volume":"68","author":"Strasser","year":"2008","journal-title":"Cancer Res"},{"key":"28","doi-asserted-by":"publisher","first-page":"3916","DOI":"10.1038\/srep03916","article-title":"Regulation of mitochondrial proliferation by PGC-1alpha induces cellular apoptosis in musculoskeletal malignancies","volume":"4","author":"Akisue","year":"2014","journal-title":"Sci Rep"},{"key":"29","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1158\/1541-7786.mcr-16-0118","article-title":"Extracellular ATP a New Player in Cancer Metabolism: NSCLC Cells Internalize ATPandUsing Multiple Endocytic Mechanisms","volume":"14","author":"Chen","year":"2016","journal-title":"Molecular Cancer Research"},{"key":"30","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.tem.2012.06.006","article-title":"Transcriptional integration of mitochondrial biogenesis","volume":"23","author":"Kelly","year":"2012","journal-title":"Trends Endocrinol Metab"},{"key":"31","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.mito.2013.01.006","article-title":"Regulation of mitochondrial biogenesis and PGC-1alpha under cellular stress","volume":"13","author":"Wenz","year":"2013","journal-title":"Mitochondrion"},{"key":"32","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1111\/j.1349-7006.2009.01144.x","article-title":"Both CD133+ and CD133- subpopulations of A549 and H446 cells contain cancer-initiating cells","volume":"100","author":"Ma","year":"2009","journal-title":"Cancer Sci"},{"key":"33","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1093\/hmg\/ddh109","article-title":"Mitochondrial transcription factor A regulates mtDNA copy number in mammals","volume":"13","author":"Larsson","year":"2004","journal-title":"Hum Mol Genet"},{"key":"34","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1016\/j.bbapap.2009.11.023","article-title":"Nutrient-dependent regulation of PGC-1alpha's acetylation state and metabolic function through the enzymatic activities of Sirt1\/GCN5","volume":"1804","author":"Puigserver","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"35","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1101\/sqb.2012.76.010439","article-title":"NAD+ as a signaling molecule modulating metabolism","volume":"76","author":"Auwerx","year":"2011","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"36","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nrc1590","article-title":"Tumour stem cells and drug resistance","volume":"5","author":"Bates","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"37","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1177\/1947601912473826","article-title":"Emerging Roles of SIRT1 in Cancer Drug Resistance","volume":"4","author":"Chen","year":"2013","journal-title":"Genes Cancer"},{"key":"38","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3892\/or.12.2.483","article-title":"The localisation and reduction of nuclear staining of PPARgamma and PGC-1 in human breast cancer","volume":"12","author":"Jiang","year":"2004","journal-title":"Oncol Rep"},{"key":"39","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.canlet.2003.08.024","article-title":"Peroxisome proliferator-activated receptors (PPARs) and associated transcription factors in colon cancer: reduced expression of PPARgamma-coactivator 1 (PGC-1)","volume":"203","author":"Meier","year":"2004","journal-title":"Cancer Lett"},{"key":"40","first-page":"593","article-title":"[Down-regulation of PGC-1alpha expression in human hepatocellular carcinoma]. [Article in Chinese]","volume":"30","author":"Zhang","year":"2008","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"41","doi-asserted-by":"publisher","first-page":"e107109","DOI":"10.1371\/journal.pone.0107109","article-title":"Expression of mitochondrial regulators PGC1alpha and TFAM as putative markers of subtype and chemoresistance in epithelial ovarian carcinoma","volume":"9","author":"Shoshan","year":"2014","journal-title":"PLoS One"},{"key":"42","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1002\/cncr.25676","article-title":"Sirtuin-3 (SIRT3), a novel potential therapeutic target for oral cancer","volume":"117","author":"Kapila","year":"2011","journal-title":"Cancer"},{"key":"43","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.ccr.2011.02.014","article-title":"SIRT3 opposes reprogramming of cancer cell metabolism through HIF1alpha destabilization","volume":"19","author":"Haigis","year":"2011","journal-title":"Cancer Cell"},{"key":"44","first-page":"2732s","article-title":"Neuromedin B is present in lung cancer cell lines","volume":"52","author":"Moody","year":"1992","journal-title":"Cancer Res"},{"key":"45","first-page":"1955","article-title":"Copper- and zinc-containing superoxide dismutase, manganese-containing superoxide dismutase, catalase, and glutathione peroxidase in normal and neoplastic human cell lines and normal human tissues","volume":"42","author":"Roos","year":"1982","journal-title":"Cancer Res"},{"key":"46","doi-asserted-by":"publisher","first-page":"7189","DOI":"10.1074\/jbc.M116.774471","article-title":"Quantifying intracellular rates of glycolytic and oxidative ATP production and consumption using extracellular flux measurements","volume":"292","author":"Brand","year":"2017","journal-title":"J Biol Chem"},{"key":"47","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1073\/pnas.011404098","article-title":"Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection","volume":"98","author":"Wong","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"48","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/biostatistics\/4.2.249","article-title":"Exploration, normalization, and summaries of high density oligonucleotide array probe level data","volume":"4","author":"Speed","year":"2003","journal-title":"Biostatistics"},{"key":"49","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/1471-2164-14-293","article-title":"A data-driven approach to preprocessing Illumina 450K methylation array data","volume":"14","author":"Schalkwyk","year":"2013","journal-title":"BMC Genomics"},{"key":"50","doi-asserted-by":"publisher","first-page":"333","DOI":"10.4161\/epi.24008","article-title":"An evaluation of analysis pipelines for DNA methylation profiling using the Illumina HumanMethylation450 BeadChip platform","volume":"8","author":"Gomez-Cabrero","year":"2013","journal-title":"Epigenetics"},{"key":"51","doi-asserted-by":"publisher","first-page":"r105","DOI":"10.1186\/gb-2013-14-9-r105","article-title":"Genome-wide signatures of differential DNA methylation in pediatric acute lymphoblastic leukemia","volume":"14","author":"Larsson","year":"2013","journal-title":"Genome Biol"},{"key":"52","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1038\/onc.2011.384","article-title":"Molecular mechanisms of cisplatin resistance","volume":"31","author":"Kroemer","year":"2012","journal-title":"Oncogene"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.21885","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T14:26:31Z","timestamp":1589207191000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.21885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,16]]},"references-count":52,"journal-issue":{"issue":"55","published-print":{"date-parts":[[2017,11,7]]}},"alternative-id":["21885","29212260"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.21885","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,16]]}}}